Author:
Jean Guillaume,Lifante Jean-Christophe,Bresson Éric,Ramackers Jean-Marie,Chazot Guillaume,Chazot Charles
Reference105 articles.
1. Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS);Young;Am J Kidney Dis.,2004
2. The DOPPS practice monitor for US dialysis care: PTH levels and management of mineral and bone disorder in US hemodialysis patients;Tentori;Am J Kidney Dis.,2015
3. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD);Kidney Int Suppl.,2009
4. Forging forward with 10 burning questions on FGF23 in kidney disease;Wolf;J Am Soc Nephrol.,2010
5. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS);Tentori;Am J Kidney Dis.,2008